Grand Challenges in Neuroscience

A screenshot from a virtual webinar or video call hosted by StarFish Medical. On the left, a man labeled 'Nick Allan' is wearing a headset and laughing, sitting in an open office space with multiple computer monitors and employees in the background. On the right, a man labeled 'Dr. Jacob Hooker' is smiling while sitting in an office with large windows, framed pictures, and artwork behind him.
Resources

Grand Challenges in Neuroscience

Authors: Nick Allan
Topic: Webinar

Advancements in neuroscience are reshaping our understanding of the human brain, but significant challenges remain in translating scientific breakthroughs into effective treatments. From overcoming the blood-brain barrier to developing more precise drug delivery methods, researchers and engineers are working to bridge the gap between discovery and patient impact.

In the webinar “Grand Challenges in Neuroscience” from January 21, 2025, Dr. Jacob Hooker, Lurie Family Professor of Radiology and Scientific Director at the Lurie Center for Autism at Massachusetts General Hospital, joins Nick Allan, Bio Services Manager at StarFish Medical, to discuss some of the biggest hurdles in neuroscience today. The conversation explores the complex interplay between chemistry, biology, and medical device engineering, offering insights into the latest innovations in neurotherapeutics, molecular imaging, and non-invasive drug delivery technologies.

Dr. Hooker shares his expertise in using positron emission tomography (PET) and functional MRI to study the molecular mechanisms of brain function and disease. He discusses how cutting-edge imaging techniques are unlocking new ways to diagnose and treat neurological disorders, neurodegenerative diseases, and psychiatric conditions. These tools address some grand challenges in modern neuroscience research.

A major focus of the discussion is the blood-brain barrier, a protective mechanism that makes it difficult to deliver therapeutics directly to the brain. The speakers examine novel strategies to bypass this challenge, including focused ultrasound, molecular engineering, and olfactory-based drug delivery systems. They also explore how medical device innovation plays a crucial role in advancing cell and gene therapy delivery, ensuring safety and efficacy while minimizing risk.

Beyond drug delivery, the webinar covers the growing role of wearables and real-time monitoring technologies in neuroscience. The potential for home-administered or regionally accessible treatments is expanding, with new engineering solutions making these approaches more feasible. Addressing these grand challenges in neuroscience is revolutionizing treatment accessibility.

The discussion also touches on the future of mental health treatments, emerging research in ALS and neurodegenerative disease, and the role of molecular glues and genetic therapies in addressing complex neurological conditions.

Whether you’re involved in medical device development, neuroscience research, or healthcare innovation, this webinar provides invaluable insights into the evolving landscape of brain health technologies.

Alt text: Two men are pictured side by side, both smiling, against a white background. In the top left corner is the StarFish Medical logo with the word "WEBINAR" written below it in purple text. The man on the left has short dark hair and is wearing a white shirt with a black sweater. The man on the right has short brown hair, a beard, and is wearing a green and blue plaid shirt.

Grand Challenges in Neuroscience

Solving mysteries of the human brain with drug delivery

Watch the recording
Diagram showing medical device at the center connected to clinicians, patients, and regulatory bodies with text 'Who are we designing for?' highlighting stakeholder mapping in MedTech design.

Understanding Medical Device Stakeholders

Every phase of a device’s life cycle involves different people with distinct needs—from clinicians and patients to service technicians and regulatory bodies.

A fluorescent protein assay sample glows under UV light as part of medical device cleaning validation testing.

Fluorescent Protein Assay Testing in Medical Devices

Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices.

Engineer assembling electronic components during medical device design transfer process.

Bridging the Design-to-Manufacturing Gap in Medical Devices

Your team is ready for design validation. The prototype performs well, test plans are in motion, and everything points to a smooth handoff to manufacturing. Then your partner calls with bad news: they can’t build the device as designed.

Contract Manufacturer Rejection - Engineering team reviews early-stage medical device design and manufacturability during a design transfer meeting at StarFish Medical.

When the CM Says No: What to Do When Your Contract Manufacturer Rejects Your Early-Stage Build

You’ve cleared the toughest engineering hurdles and proven your design works. Then, just as you prepare to scale, your contract manufacturer turns you down.